The potential of phytochemicals in promoting a healthy human diet to combat chronic disease.
Kyverna expands Series B with $60m to develop CAR-Ts for autoimmune disorders
Kyverna Therapeutics has added a further $60m as part of its Series B extension. Credit: Paul Craft via Shutterstock. US-based Kyverna Therapeutics has added a